The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here's what we know.

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

That data suggested the possibility that the updated booster might not be any more effective at preventing Covid ... the FDA advisers’ meeting, the agency authorized the Moderna bivalent vaccines.

This safety concern has not been identified with Moderna's (MRNA.O) bivalent shot and both the CDC and FDA continue to recommend ... EU may pay more for Pfizer COVID shots in return for lower ...

A vaccine safety monitoring system detected a "safety signal" that Pfizer's bivalent booster ... and older stay up to date on their COVID-19 shots. The FDA's Vaccines and Related Biological ...

The FDA also "asked its panel of external advisers to consider the usage of two COVID vaccine shots a year for some ... "we fully expect that the updated bivalent vaccines containing BA.

Pfizer/BioNtech and Moderna's bivalent shots ... Both the CDC and FDA continue to recommend that everyone aged six months and older stay up-to-date with their COVID-19 vaccination, despite ...

And while Tedros said "there is no doubt that we're in a far better situation now" than a year ago when the omicron variant ...

Six of the eight studies showed the bivalent booster is more effective against the BA.5 variant, compared to the original booster shots ... of COVID-19 Vaccinations in the U.S.” FDA: “Vaccine ...